- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04612842
Engaging Older Adults in Fall Prevention Using Motivational Interviewing (MI)
July 22, 2024 updated by: Hiroko Kiyoshi-Teo, Oregon Health and Science University
This mixed-methods, two-arm, randomized controlled trial will evaluate the impact of Motivational Interviewing (MI) as a follow-up care to patients who received fall prevention recommendations at Oregon Health & Science University Internal Medicine and Geriatrics Clinic provided over 12 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The goal of this mixed-methods, two-arm, randomized controlled trial of MI intervention for fall prevention is to evaluate the impact of Motivational Interviewing (MI) as a follow-up care to patients who received fall prevention recommendations at Oregon Health & Science University Internal Medicine and Geriatrics Clinic provided over 12-months.
Older adult participants (older than 65) who are at increased risk for falling will be enrolled into the study.
Patients will be randomly assigned to two groups: MI and the standard of care group.
All participants will have a baseline and 6-months study visit that will include self-report and physiologic assessment.
In addition, all participants will receive study measurement phone call at 3-, and 12-months.
MI will be provided via video, phone, or in-person one week after the initial visit and then monthly for 6 months.
All MI sessions will be recorded and encounter notes will be completed.
Purposefully selected participants' MI sessions will be transcribed for qualitative analysis.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Oregon Health & Science University (OHSU) Internal Medicine and Geriatrics Clinic patients
- 65 years old or older
- Moderate-to-high risk for falling using the STEADI fall screening and management algorithm
- Cognitively oriented (Mini-Cog≥ 3)
- Able to converse audibly and coherently in English
- Living independently in the community
- Able to receive study phone calls
- Ambulatory with or without assistive device use
Exclusion Criteria:
- Cognitively impaired patients (Mini-Cog< 2)
- Patients who have sensory difficulty with verbal communication (hard-of-hearing despite the use of hearing aids or speech is hard to understand despite a talking device)
- Living in institutions with 24-hour care such as skilled nursing facilities
- Unable to stand without assistance by others
- Life-expectancy of less than 3-months
- Patients participating in other studies that may impact fall-related behavior change
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing (MI) goup
The MI experimental group will receive the same measurements as the control group, and in addition, receive MI-based communication about fall prevention at eight occasions during the 6-month period.
MI is an evidence-based communication approach for various health behavior change.
|
The PI and two study staff members (interventionists) will conduct study visits and phone calls.
The same person will complete participant follow-ups to establish rapport and consistency.
All of the study encounters will be audio recorded with participants' permission and study encounter notes will be completed by the interventionist.
Interventionists will facilitate MI sessions using the MI guide and a participant handout.
The goal of each MI session is to identify a specific fall prevention behavior, the participant's goal with this behavior, readiness to change, specific plan to move toward the goal, barriers and facilitators, and the participant's commitment level to change.
|
|
No Intervention: Control group
The control group participants will take part in study measurements (self-report and physiologic assessment) for 12-months.
Primary assessment measures are at baseline, 6-, and 12-months and will be conducted via phone survey, video assessment, or mail-in calendar.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Falls Self-Efficacy Scale-International (FES-I) Results
Time Frame: 3-, 6-, and 12-months
|
A 7-item scale, 1-4 self-report rating, widely used to measure levels of concern related to preventing falls.
Minimum value is 7 and maximum value is 28.
Higher FES-I scores is a worse value since it has been positively correlated with decreased activities, future falls, and injury.
|
3-, 6-, and 12-months
|
|
Fall Behavioral (FAB) Scale Results
Time Frame: 3-, 6-, and 12-months
|
A 24-item, 1-4 self-report rating to measure frequency of protective strategies to prevent falling and risky behaviors that facilitate a fall.
The average value is calculated with a minimum value of 1 and maximum value of 4. Higher FAB score is a better value since it indicates more consistent fall protective behaviors.
|
3-, 6-, and 12-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Activation Measure Results
Time Frame: 3-, 6-, and 12-months
|
100-point, quantifiable scale determining patient engagement in healthcare.
Minimum value is 0 and the maximum value is 100.
Higher value is a better value since it is indicative of participant's activation with their healthcare.
|
3-, 6-, and 12-months
|
|
Level of Confidence to Prevent Falls
Time Frame: 3-, 6-, and 12-months
|
1-item 10-point scale response.
Often used in motivational interviewing sessions to gauge an individual's readiness to engage in certain health behaviors.
Higher levels of confidence are known to be associated with an increased rate of behavior change.
|
3-, 6-, and 12-months
|
|
Level of Importance to Prevent Falls
Time Frame: 3-, 6-, and 12-months
|
1-item 10-point scale response.
Often used in motivational interviewing sessions to gauge an individual's readiness to engage in certain health behaviors.
Higher levels of importance are known to be associated with an increased rate of behavior change.
|
3-, 6-, and 12-months
|
|
Balance Measure (Feet Side by Side)
Time Frame: 6- months
|
Duration that participants can hold feet side-by-side stand (heel to toe standing positions) will be measured up to 10 seconds.
Minimum value is 0 seconds and maximum score is 10 seconds.
Higher value is a better value since it is indicative of participants' ability to hold balance.
|
6- months
|
|
Balance Measure (Semi-tandem Stand)
Time Frame: 6- months
|
Duration that participants can hold semi-tandem stand (heel to toe standing positions) will be measured up to 10 seconds.
Minimum value is 0 seconds and maximum score is 10 seconds.
Higher value is a better value since it is indicative of participants' ability to hold balance.
|
6- months
|
|
Balance Measure (Tandem Stand)
Time Frame: 6-months
|
Individuals are asked to hold a tandem stand (one foot in front of the other- heel touching toe).
The minimum is 0 and the maximum is 10.
A higher number is a better outcome.
|
6-months
|
|
Balance Measure (One-leg Stand)
Time Frame: 6- months
|
Individuals are asked to hold a balance position for 10 sections without moving their feet or needing support.
This position require standing on one foot.
The minimum is 0 and the maximum is 10.
A higher number is a better outcome.
|
6- months
|
|
30-second Sit-to-stand Assessment
Time Frame: 6-months
|
Instances that participants can stand from a sitting position will be measured.
Minimum value is 0 times.
Higher value is a better value since it is indicative of participants' ability to sit-to-stand.
|
6-months
|
|
Number of Participants With Self-reported Falls
Time Frame: 1-year
|
Individuals were asked to mail-in reports of falls every month.
Participants reporting a fall at least once are counted as a faller.
Minimum value is 0. Higher value is worse value as it is indicative that there were more participants who fell during the year.
|
1-year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Hiroko Kiyoshi-Teo, PhD, Oregon Health and Science University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 9, 2020
Primary Completion (Actual)
March 24, 2023
Study Completion (Actual)
September 28, 2023
Study Registration Dates
First Submitted
October 8, 2020
First Submitted That Met QC Criteria
October 27, 2020
First Posted (Actual)
November 3, 2020
Study Record Updates
Last Update Posted (Actual)
August 13, 2024
Last Update Submitted That Met QC Criteria
July 22, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00008993
- K23NR018672 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data to be shared with other researchers are: individual participant data that underlie the results reported in the publication after deidentification.
IPD Sharing Time Frame
Beginning 9 months after and ending 36 months following the publication of the data.
IPD Sharing Access Criteria
Investigators whose proposed use of data has been approved by an independent review committee.
Proposal to use the data may be submitted up to 36 months following article publication.
After 36 months, data will be available in OHSU data warehouse.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.